UOC
ZYME icon

UBS O'Connor’s Zymeworks ZYME Stock Holding History

UBS O'Connor’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54,457
Closed -$573K – 645
2024
Q1 		$573K Sell
54,457
-81,856
-60% -$909K 0.02% 324
2023
Q4 		$1.42M Sell
136,313
-208,159
-60% -$1.66M 0.04% 228
2023
Q3 		$2.18M Buy
344,472
+25,000
+8% +$185K 0.04% 231
2023
Q2 		$2.76M Buy
319,472
+15,740
+5% +$141K 0.06% 211
2023
Q1 		$2.75M Buy
+303,732
New +$2.65M 0.07% 220
2022
Q4 		– Sell
-215,000
Closed -$1.32M – 351
2022
Q3 		$1.32M Buy
215,000
+119,000
+124% +$717K 0.02% 710
2022
Q2 		$509K Buy
+96,000
New +$581K 0.01% 813

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

UBS O'Connor's ZYME Position: Q2 2024 in Review

UBS O'Connor sold out of Zymeworks (ZYME) in Q2 2024, closing a stake of 54,457 shares — an estimated $573K sold.

UBS O'Connor first reported a position in ZYME in Q2 2022 and held it in 7 quarters. The position peaked at $2.76M in Q2 2023. 164 funds tracked by Wall St. Rank hold ZYME as of Q2 2024.

  • UBS O'Connor reported no remaining Zymeworks position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 54,457 Zymeworks shares in Q2 2024, an estimated $573K.
  • UBS O'Connor first reported a position in Zymeworks in Q2 2022 and held it in 7 quarters.
  • UBS O'Connor's Zymeworks position peaked at $2.76M in Q2 2023.
  • 164 funds tracked by Wall St. Rank held Zymeworks as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.